MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
Go back to MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology| (AMEX: MKKGY) | Delayed: 31.90 -0.49 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.39 | 52 Week High | $ | |||
| Open | $32.04 | 52 Week Low | $ | |||
| Day High | $32.11 | P/E | N/A | |||
| Day Low | $31.76 | EPS | $ | |||
| Volume | 12,287 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 126.69 -2.17 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.86 | 52 Week High | $65.46 | |||
| Open | $128.34 | 52 Week Low | $47.97 | |||
| Day High | $128.99 | P/E | 86.18 | |||
| Day Low | $125.65 | EPS | $1.47 | |||
| Volume | 3,258,336 | |||||
